Rebecca Harding

Rebecca Harding is a PhD candidate at the Clinical Psychopharmacology Unit at University College London. Her research focuses on understanding the brain mechanisms underlying addiction, with the goal of guiding the development of novel treatment interventions such as psychedelics. Rebecca is also interested in the abuse potential of ketamine. She is committed to research-led drug policy and raising awareness of the risks associated with ketamine use, ensuring a balanced understanding of both its therapeutic potential and its potential for misuse.